Northwest Biotherapeutics reported $-13.41M in EBITDA for its fiscal quarter ending in September of 2023.





Ebitda Change Date
Agenus USD -10.11M 19.02M Mar/2025
AstraZeneca USD 5.16B 510M Jun/2026
Bristol-Myers Squibb USD 4.24B 1.37B Mar/2026
Celldex Therapeutics USD -83.58M 2.76M Mar/2026
Eisai JPY 34.15B 34.48B Jun/2026
Merck USD -1.54B 7.84B Mar/2026
Northwest Biotherapeutics USD -13.41M 232K Sep/2023
Pfizer USD 6.01B 18M Jun/2026
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Roche Holding CHF 13.43B 744M Jun/2026